---
category: news
title: "Lilly, Biolojic to develop antibody therapies for diabetes treatment"
excerpt: "Eli Lilly has signed a research collaboration and license agreement with Biolojic Design to discover and develop therapies for diabetes treatment."
publishedDateTime: 2021-03-09T09:21:00Z
originalUrl: "https://www.pharmaceutical-business-review.com/news/lilly-biolojic-antibody-therapies-diabetes/"
webUrl: "https://www.pharmaceutical-business-review.com/news/lilly-biolojic-antibody-therapies-diabetes/"
ampWebUrl: "https://www.pharmaceutical-business-review.com/news/lilly-biolojic-antibody-therapies-diabetes/amp/"
cdnAmpWebUrl: "https://www-pharmaceutical--business--review-com.cdn.ampproject.org/c/s/www.pharmaceutical-business-review.com/news/lilly-biolojic-antibody-therapies-diabetes/amp/"
type: article
quality: 24
heat: 24
published: false

provider:
  name: Pharmaceutical Business Review
  domain: pharmaceutical-business-review.com

topics:
  - AI in Healthcare
  - AI

secured: "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;0YAnqrlj6a4O94aOh1aGsQ=="
---

